The Haleon share price continues to fall! Is it now a prime buying opportunity?

This Fool takes a closer look at the Haleon share price journey recently. With it falling, he considers if there is a buying opportunity.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since Haleon’s (LSE:HLN) demerger with GSK and independent listing on the FTSE 100 last month, its shares have been falling. I can’t help but wonder if the Haleon share price falls into the category of a prime buying opportunity for my holdings with a view to a recovery? Let’s take a closer look.

Haleon share price journey

As a quick reminder, Haleon is now the largest standalone consumer healthcare goods business in the world. This comes after its demerger from global giant GSK. Some of its best known brands are staples in many consumer’s medicine cabinets, mine included, and include Night Nurse, Beechams, Piriteze, and Sensodyne to name a few.

So what’s the current state of play with the Haleon share price? Well, the shares listed last month for a price of 320p per share. As I write, they’re trading for 268p, which is a 16% decline in approximately a month. It is worth noting that the listing was the largest in Europe for close to a decade.

The investment case

Let’s start with some positives around Haleon shares then. I am buoyed by a few key elements. Firstly, the strength and brand power of some of its brands is unrivalled in the consumer healthcare market. These could help boost sales, performance, investor sentiment, and returns in the longer term.

Next, I noticed that a number of insiders have been buying shares since the Haleon share price listed. I find this positive, as who better to attest to the direction and potential of a business than those with an inside track. Haleon Chairman Sir Dave Lewis purchased £200,000 worth of shares just after the listing. Furthermore, two non-executive directors spent approximately £65,000 on shares too.

Finally, Haleon upgraded its forecast for its first full-year update when it released a half-year report at the end of July. The H1 update made for excellent reading, in my opinion. Revenue increased by close to 14% compared to the year previous, driven by organic growth, higher prices, and increased volumes. It also pointed towards the power-boosting performance of certain of its brands, namely Panadol, Advil, and Centrum. However, the positive report did not boost the Haleon share price.

So to some risks associated with Haleon shares then. Firstly, macroeconomic headwinds could have a longer-term impact on results and returns. Soaring inflation, the rising cost of materials, as well as the global supply chain issues could affect profitability and operations.

Next, I’m a bit worried by Haleon’s current debt levels. Debt is usually a red flag for me because it can impact levels of returns and future growth plans. I want to see further results and how the company plans to pay down debt, as well as growth plans to learn more.

What I’m doing now

I do believe that Haleon could be a good stock to buy for growth and returns in the longer term. Furthermore, analysts believe the Haleon share price will recover and increase steadily. I am keen to learn a bit more about the company’s direction, as well as its plan to combat current debt levels in the coming months and updates ahead, however.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jabran Khan has no position in any of the shares mentioned. The Motley Fool UK has recommended Haleon plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

artificial intelligence investing algorithms
Investing Articles

If I’d invested £10k in AstraZeneca shares three months ago here’s what I’d have now

Harvey Jones is kicking himself for failing to buy AstraZeneca shares before the took off. Is there still a decent…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How I’d find shares to buy for an early retirement

Christopher Ruane explains some of the factors he considers when looking for shares to buy that could potentially help him…

Read more »

Investing Articles

Why I’d snap up bargain UK shares to try and build wealth

Christopher Ruane explains how he hopes to find high-quality UK shares selling at attractive prices, to help him build wealth…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

Here’s how I’d target a £2k annual second income from a £20k Stocks & Shares ISA

Our writer explains how he’d try to earn thousands of pounds annually in dividends by investing a £20k ISA in…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Investing Articles

The £20k Stocks and Shares ISA might be one of the better things about living in the UK

The £20k Stocks and Shares ISA doesn't have many equivalents in other countries. Here's why these accounts can help UK…

Read more »

Google office headquarters
Investing Articles

Growth or income: what should my SIPP target?

Should our writer concentrate his SIPP on growth or income shares, or buy a mixture of both? Here he considers…

Read more »

Black father and two young daughters dancing at home
Investing Articles

£17,365 in savings? Here’s how I’d invest that in dividend shares for long-term passive income

Interest rates might be higher than inflation, but Stephen Wright thinks the stock market is still the place to be…

Read more »